Fangfang Liu
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Targeting the CTBP1-CETP axis overcomes ferroptosis resistance in non-small cell lung cancer by altering lipid accumulation.
Journal: Clinical and translational medicine
Published: April 22, 2026
Cellular senescence in lung cancer immune microenvironment and senotherapeutic opportunities.
Journal: iScience
Published: February 12, 2026
Peripheral blood IFN-γ-producing T-cell subsets and soluble IL-2 receptor as independent prognostic biomarkers in NSCLC treated with immune checkpoint inhibitor-based therapy.
Journal: Discover oncology
Published: February 09, 2026
Glycolytic reprogramming in cancer: tumour cell metabolism, immune modulation, and therapeutic opportunities.
Journal: Journal of translational medicine
Published: January 21, 2026
Publisher Correction: SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.
Journal: Nature cell biology
Published: January 19, 2026
HE4 drives PD-L1 expression in myeloid cells via IFN-γR-JAK-STAT3 signaling to promote tumor immune evasion.
Journal: Cell reports. Medicine
Published: September 03, 2025
Intermediate accumulated upon interruption of fatty acid oxidation flux promotes tumoral ferroptosis and improves immunotherapy.
Journal: Nature communications
Published: August 29, 2025
Diagnostic Value of CDO1 Promoter Methylation in Lung Cancer via Liquid Biopsy: A Systematic Review and Meta-Analysis.
Journal: Frontiers in bioscience (Landmark edition)
Published: June 18, 2025
SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.
Journal: Nature cell biology
Published: June 02, 2025
Clinicopathological and molecular characteristics and treatment outcomes of SMARCA4-deficient thoracic tumors: a comprehensive analysis.
Journal: The oncologist
Published: February 23, 2025
A prospective multi-cohort study identifies and validates a 5-gene peripheral blood signature predictive of immunotherapy response in non-small cell lung cancer.
Journal: Molecular cancer
Published: June 12, 2024
Last Updated: 09/26/2026